Experienced in Glaucoma

Toke Bek

Palle Juul Jensens Boulevard 99, 
Aarhus N, DK 
Experienced in Glaucoma
Palle Juul Jensens Boulevard 99, 
Aarhus N, DK 
OverviewLocationsClinical Research

Overview

Toke Bek practices in Aarhus N, Denmark. Bek is rated as an Experienced expert by MediFind in the treatment of Glaucoma. Their top areas of expertise are Diabetic Retinopathy, Retinal Vein Occlusion, Cerebral Hypoxia, Vitrectomy, and Cataract Removal.

Their clinical research consists of co-authoring 177 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Glaucoma.

Locations

Palle Juul Jensens Boulevard 99, Aarhus N, 8200, Denmark
Other Locations
Palle Juul Jensens Boulevard 167, Aarhus N, 8200, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Acetylsalicylic acid
Study Phase: Phase 3
Low-dose Atropine for the Prevention of Myopia Progression in Danish Children - a Randomized, Double-masked, Multicenter, 36-month Prospective 1:1:1 Study of Safety and Efficacy of 0.1% Atropine Loading Dose to Single 0.01% Atropine and Placebo
Low-dose Atropine for the Prevention of Myopia Progression in Danish Children - a Randomized, Double-masked, Multicenter, 36-month Prospective 1:1:1 Study of Safety and Efficacy of 0.1% Atropine Loading Dose to Single 0.01% Atropine and Placebo
Enrollment Status: Completed
Publish Date: June 29, 2025
Intervention Type: Drug
Study Drugs: Atropine, Sodium-chloride
Study Phase: Phase 2
Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Factors: New Perspectives
Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Factors: New Perspectives
Enrollment Status: Completed
Publish Date: November 22, 2024
Identification of Biomarkers for Early Detection of Diabetes Complications by Characterisation of Circulating Endothelial Cells in Human Blood Using Single-cell RNA Sequencing.
Identification of Biomarkers for Early Detection of Diabetes Complications by Characterisation of Circulating Endothelial Cells in Human Blood Using Single-cell RNA Sequencing.
Enrollment Status: Completed
Publish Date: August 20, 2024
View 3 Less Clinical Trials

177 Total Publications

Systemic Hypoxia Increases Retinal Blood Flow but Reduces the Oxygen Saturation Less in Peripheral Than in Macular Vessels in Normal Persons.
Systemic Hypoxia Increases Retinal Blood Flow but Reduces the Oxygen Saturation Less in Peripheral Than in Macular Vessels in Normal Persons.
Journal: Investigative ophthalmology & visual science
Published: June 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bek's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile